{"id":"W2990486470","doi":"10.1017/cjn.2019.83","title":"A.01 Relieving the burden of myasthenia gravis: eculizumab reduces exacerbation, hospitalization and rescue therapy rates","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Hospital Edmonton","funders":"","keywords":"Eculizumab; Medicine; Exacerbation; Myasthenia gravis; Internal medicine; Plasmapheresis; Placebo; Complement system; Antibody; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001067156,0.000181305,0.0007268487,0.0001727284,0.00007619383,0.0003949668,0.0002515211,0.0003186217,0.005169342],"category_scores_gemma":[0.001774126,0.0001080561,0.0005321322,0.0001458461,0.0001755548,0.0002913209,0.0002227326,0.0006376754,0.0006499478],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001668234,"about_ca_system_score_gemma":0.0002237438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004224096,"about_ca_topic_score_gemma":0.0005160329,"domain_scores_codex":[0.999535,0.000227695,0.00003287583,0.0000543869,0.00009081334,0.00005929377],"domain_scores_gemma":[0.9989061,0.0003980534,0.0004399401,0.0000580503,0.00004754494,0.0001501977],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1663874,0.01338612,0.08888374,0.00130454,0.002208642,0.0002559267,0.0002928287,0.001360292,0.02206935,0.0002790916,0.005437021,0.6981351],"study_design_scores_gemma":[0.0350766,0.1220313,0.8157471,0.0003322148,0.001985458,0.001644703,0.0002491099,0.007279787,0.007734659,0.0003240278,0.007565829,0.00002921716],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994341,0.003153112,0.0002462205,0.0002881295,0.00002831645,0.00006311645,0.0002339806,0.00006403706,0.001582034],"genre_scores_gemma":[0.9974806,0.0005610007,0.000407477,0.0001331508,0.0000595817,0.00004563358,0.0002090766,0.000008541056,0.001095036],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005169342,"threshold_uncertainty_score":0.01729316,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02111773359461203,"score_gpt":0.2655112880343818,"score_spread":0.2443935544397698,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}